Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Becton Dickinson And Company (IT:1BDX)
:1BDX
Holding IT:1BDX?
Track your performance easily
Earnings Data
Report Date
Feb 06, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
2.9Last Year’s EPS
2.6Same Quarter Last Year
Strong Buy
Based on 10 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 06, 2018
|% Change Since: 2.87%
|Next Earnings Date:Aug 02, 2018
Earnings Call Sentiment|Neutral
The earnings call presented a balanced view with strong growth in key segments and operational improvements, tempered by challenges in China and bioscience markets. Overall, BD is well-positioned for FY '25 with a focus on innovation and strategic growth opportunities.Company Guidance
During BD's earnings call for Q4 2024, the company provided comprehensive guidance for fiscal year 2025, focusing on high single-digit revenue growth and a commitment to margin expansion. BD anticipates delivering revenue in the range of $21.9 billion to $22.1 billion, reflecting an 8.8% to 9.3% currency-neutral adjusted revenue growth. The guidance incorporates a 125 basis points headwind from market dynamics in China and the bioscience pharma sector, with China expected to decline by mid-single digits. BD projects adjusted EPS growth of about 10% at the midpoint, despite facing headwinds from increased acquisition-related interest expenses and a higher tax rate, inclusive of Pillar 2. The company also plans to expand adjusted operating margins by approximately 100 basis points, exceeding the previously set goal of 25%, primarily driven by gross margin improvements. Additionally, BD aims to deploy approximately $1 billion towards share repurchases over the next 12 to 18 months while maintaining its target leverage of 2.5x.Strong Q4 Results and Full Year EPS Growth
Q4 revenue growth of 7.4% organically, 120 basis points of margin expansion, and adjusted diluted EPS up 11.4%. Full year EPS of $13.14, adjusted operating margin of 24.2%, and free cash flow of $3.1 billion.
Advancements in BD Medical and Interventional
In FY '24, BD Medical surpassed $1 billion in biologic drug delivery sales. BD Interventional saw strong growth with the PureWick platform and advanced tissue regeneration.
Operational Excellence and Margin Improvement
BD Excellence initiatives led to improvements in waste and operating equipment efficiency, contributing to margin expansion and cash flow above plan.
Positive Cash Flow and Capital Deployment
Free cash flow increased by 47% to $3.1 billion. Announced 53rd consecutive year of dividend increases and planned $1 billion for share repurchases over the next 12 to 18 months.
---
IT:1BDX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
IT:1BDX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 07, 2024 | €221.25 | €213.09 | -3.69% |
| Aug 01, 2024 | €219.87 | €211.14 | -3.97% |
| May 02, 2024 | €215.73 | €217.70 | +0.92% |
| Feb 01, 2024 | €217.32 | €216.33 | -0.45% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Becton Dickinson And Company (IT:1BDX) report earnings?
Becton Dickinson And Company (IT:1BDX) is schdueled to report earning on Feb 06, 2025, TBA Not Confirmed.
What is Becton Dickinson And Company (IT:1BDX) earnings time?
Becton Dickinson And Company (IT:1BDX) earnings time is at Feb 06, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Becton Dickinson And Company stock?
The P/E ratio of Becton Dickinson is N/A.
What is IT:1BDX EPS forecast?
IT:1BDX EPS forecast for the fiscal quarter 2025 (Q1) is 2.9.
---